GENENTA SCIENCE S P A GNTA
SPONSORED ADS · ADR · CUSIP 36870W100
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.84.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 3 |
| Q4 2022 | 5 |
| Q1 2023 | 3 |
| Q2 2023 | 5 |
| Q3 2023 | 4 |
| Q4 2023 | 5 |
| Q1 2024 | 6 |
| Q2 2024 | 6 |
| Q3 2024 | 6 |
| Q4 2024 | 5 |
| Q1 2025 | 6 |
| Q2 2025 | 6 |
| Q3 2025 | 6 |
| Q4 2025 | 15 |
| Q1 2026 | 11 |
| Q2 2026 | 9 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 2 | 0 |
| Q4 2024 | 1 | 2 |
| Q1 2025 | 4 | 1 |
| Q2 2025 | 2 | 2 |
| Q3 2025 | 3 | 1 |
| Q4 2025 | 7 | 1 |
| Q1 2026 | 5 | 7 |
| Q2 2026 | 3 | 7 |
Biggest buyers
| Virtu Financial LLC | New | +36.9k |
| Ground Swell Capital, LLC | New | +14.4k |
| Simplicity Wealth,LLC | Added | +6.4k |
Biggest sellers
| AlTi Global, Inc. | Sold out | -200.3k |
| SmartHarvest Portfolios, LLC | Reduced | -90.6k |
| Independent Advisor Alliance | Sold out | -37.0k |
| XTX Topco Ltd | Sold out | -24.5k |
| MORGAN STANLEY | Sold out | -15.4k |
| GAMMA Investing LLC | Reduced | -4.4k |
| UBS Group AG | Reduced | -80 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Nuzzo Marco
13D · may seek influence
-11.5 pts · filed 2026-10-02
Stated purposeItem 4 is hereby amended and supplemented by adding the following thereto: On June 12, 2026, the Court of Milan granted interim relief suspending the effectiveness of the resolution adopted at the Issuer's extraordinary shareholders' meeting on October 29, 2025 concerning the amendment to the Issuer's corporate purpose. On July 9, 2026, a panel of the Court of Milan revoked that interim relief following a challenge filed by the Issuer. The proceedings on the merits remain pending. Between August 7, 2026 and August 19, 2026, Fin Posillipo S.p.A. ("Posillipo") acquired 110,000 ADSs in open-market transactions at a price of $1.30 per ADS. Posillipo made these purchases for its own account. The purchases were not planned, directed, or coordinated by, and were not made pursuant to any agreeme… Full filing |
11.5% |
| Pierluigi Paracchi 13G · exempt (held before listing) -2.8 pts · filed 2026-01-27 | 9.8% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Eurizon Capital SGR S.p.A. 0.00% of their portfolio | 360.0k $662.4k | Unchanged |
| Allianz SE 0.00% of their portfolio | 234.1k $430.7k | Unchanged |
| SmartHarvest Portfolios, LLC 0.03% of their portfolio | 43.9k $80.7k | Reduced -90.6k |
| Virtu Financial LLC 0.00% of their portfolio | 36.9k $68.0k | New |
| Simplicity Wealth,LLC 0.00% of their portfolio | 18.6k $34.2k | Added +6.4k |
| Ground Swell Capital, LLC 0.03% of their portfolio | 14.4k $26.4k | New |
| GAMMA Investing LLC 0.00% of their portfolio | 9.9k $18.1k | Reduced -4.4k |
| UBS Group AG 0.00% of their portfolio | 3.0k $5.6k | Reduced -80 |
| Farther Finance Advisors, LLC 0.00% of their portfolio | 3 $6 | Unchanged |